Zeitschriftenartikel zum Thema „Saligenin“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Machen Sie sich mit Top-50 Zeitschriftenartikel für die Forschung zum Thema "Saligenin" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Sehen Sie die Zeitschriftenartikel für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.
Bakker, Daniël J., Arghya Dey, Daniel P. Tabor, Qin Ong, Jérôme Mahé, Marie-Pierre Gaigeot, Edwin L. Sibert und Anouk M. Rijs. „Fingerprints of inter- and intramolecular hydrogen bonding in saligenin–water clusters revealed by mid- and far-infrared spectroscopy“. Physical Chemistry Chemical Physics 19, Nr. 31 (2017): 20343–56. http://dx.doi.org/10.1039/c7cp01951c.
Der volle Inhalt der QuelleSaragi, Rizalina Tama, Marcos Juanes, José Luis Abad, Alberto Lesarri, Ruth Pinacho und José Emiliano Rubio. „Rotational spectroscopy of organophosphorous chemical agents: cresyl and phenyl saligenin phosphates“. Physical Chemistry Chemical Physics 21, Nr. 30 (2019): 16418–22. http://dx.doi.org/10.1039/c9cp03093j.
Der volle Inhalt der QuelleGlynn, P., D. J. Read, R. Guo, S. Wylie und M. K. Johnson. „Synthesis and characterization of a biotinylated organophosphorus ester for detection and affinity purification of a brain serine esterase: neuropathy target esterase“. Biochemical Journal 301, Nr. 2 (15.07.1994): 551–56. http://dx.doi.org/10.1042/bj3010551.
Der volle Inhalt der QuelleSingh, Vishwakarma, Punitha Vedantham und Pramod K. Sahu. „A novel stereoselective total synthesis of (±)-hirsutene from saligenin“. Tetrahedron Letters 43, Nr. 3 (Januar 2002): 519–22. http://dx.doi.org/10.1016/s0040-4039(01)02183-9.
Der volle Inhalt der QuelleLushchekina, S. V., V. S. Polomskikh, S. D. Varfolomeev und P. Masson. „Molecular modeling of butyrylcholinesterase inhibition by cresyl saligenin phosphate“. Russian Chemical Bulletin 62, Nr. 11 (November 2013): 2527–37. http://dx.doi.org/10.1007/s11172-013-0366-9.
Der volle Inhalt der QuelleShiotsuki, Takahiro, Takeshi Kakimoto und Morifusa Eto. „Irreversible inactivation of glutathione transferases by saligenin cyclic phosphates“. Pesticide Biochemistry and Physiology 42, Nr. 2 (Februar 1992): 119–27. http://dx.doi.org/10.1016/0048-3575(92)90059-9.
Der volle Inhalt der QuelleSHIOTSUKI, Takahiro. „Mode of Action of Saligenin Cyclic Phosphates on Organophosphate-Resistant Houseflies“. Journal of Pesticide Science 16, Nr. 3 (1991): 523–31. http://dx.doi.org/10.1584/jpestics.16.523.
Der volle Inhalt der QuelleLidsky, T. I., C. Manetto und M. Ehrich. „Nerve conduction studies in chickens given phenyl saligenin phosphate and corticosterone“. Journal of Toxicology and Environmental Health 29, Nr. 1 (Januar 1990): 65–75. http://dx.doi.org/10.1080/15287399009531372.
Der volle Inhalt der QuelleTorgul, M., M. SÜnkÜr, F. B. Kaynak, H. HosgOren und S. Ozbey. „Saligenin derivative borocryptands: synthesis and structural analysis of new type lithium borocryptate“. Journal of Chemical Research (Miniprint) 2003, Nr. 10 (01.10.2003): 605. http://dx.doi.org/10.3184/030823503322655670.
Der volle Inhalt der QuelleTogrul, M., M. SÜnkÜr, F. B. Kaynak, H. HosgOren und S. Ozbey. „Saligenin derivative borocryptands: synthesis and structural analysis of new type lithium borocryptate“. Journal of Chemical Research 2003, Nr. 10 (01.10.2003): 605. http://dx.doi.org/10.3184/030823403322655770.
Der volle Inhalt der QuelleSHIOTSUKI, Takahiro, Akihiro KOISO und Morifusa ETO. „Glutathione Conjugation as a Mechanism for Glutathione Transferase Inhibition by Saligenin Cyclic Phosphates“. Journal of Pesticide Science 14, Nr. 3 (1989): 337–44. http://dx.doi.org/10.1584/jpestics.14.337.
Der volle Inhalt der QuelleXu, Lin-Lin, Meng-Ling Liu, Jing-Lei Wang, Mei Yu und Jia-Xiang Chen. „Saligenin cyclic-o-tolyl phosphate (SCOTP) induces autophagy of rat spermatogonial stem cells“. Reproductive Toxicology 60 (April 2016): 62–68. http://dx.doi.org/10.1016/j.reprotox.2016.01.004.
Der volle Inhalt der QuelleJortner, B. S., und M. Enrich. „PATHOLOGICAL EFFECTS OF PHENYL SALIGENIN PHOSPHATE, A POTENT NEUROTOXIC CONGENER OF TRIORTHOTOLYL PHOSPHATE“. Journal of Neuropathology and Experimental Neurology 45, Nr. 3 (Mai 1986): 359. http://dx.doi.org/10.1097/00005072-198605000-00134.
Der volle Inhalt der QuelleFlaskos, John, Magdalini Sachana, Michèle Pen, Wayne C. Harris und Alan J. Hargreaves. „Effects of phenyl saligenin phosphate on phosphorylation of pig brain tubulin in vitro“. Environmental Toxicology and Pharmacology 22, Nr. 1 (Juli 2006): 70–74. http://dx.doi.org/10.1016/j.etap.2005.12.006.
Der volle Inhalt der QuelleSaracila, Mihaela, Tatiana Dumitra Panaite, Camelia Puia Papuc und Rodica Diana Criste. „Heat Stress in Broiler Chickens and the Effect of Dietary Polyphenols, with Special Reference to Willow (Salix spp.) Bark Supplements—A Review“. Antioxidants 10, Nr. 5 (27.04.2021): 686. http://dx.doi.org/10.3390/antiox10050686.
Der volle Inhalt der QuelleBosak, Anita, Anamarija Knežević, Ivana Gazić Smilović, Goran Šinko und Zrinka Kovarik. „Resorcinol-, catechol- and saligenin-based bronchodilating β2-agonists as inhibitors of human cholinesterase activity“. Journal of Enzyme Inhibition and Medicinal Chemistry 32, Nr. 1 (01.01.2017): 789–97. http://dx.doi.org/10.1080/14756366.2017.1326109.
Der volle Inhalt der QuelleKnežević, Anamarija, Jurica Novak, Anita Bosak und Marijana Vinković. „Structural isomers of saligenin-based β2-agonists: synthesis and insight into the reaction mechanism“. Organic & Biomolecular Chemistry 18, Nr. 47 (2020): 9675–88. http://dx.doi.org/10.1039/d0ob02095h.
Der volle Inhalt der QuelleBurka, Leo T., und Robert E. Chapin. „Toxicokinetics of [14C]-saligenin cyclic-o-tolyl phosphate in anesthetized male F-344 rats“. Reproductive Toxicology 7, Nr. 1 (Januar 1993): 81–86. http://dx.doi.org/10.1016/0890-6238(93)90013-w.
Der volle Inhalt der QuelleProcopiou, Panayiotis A., Victoria J. Barrett, Alison J. Ford, Brian E. Looker, Gillian E. Lunniss, Deborah Needham, Claire E. Smith und Graham Somers. „The discovery of long-acting saligenin β2 adrenergic receptor agonists incorporating a urea group“. Bioorganic & Medicinal Chemistry 19, Nr. 20 (Oktober 2011): 6026–32. http://dx.doi.org/10.1016/j.bmc.2011.08.043.
Der volle Inhalt der QuelleKuran, Witold, und Ewa Mazanek. „Synthesis of novel monomeric zinc—oxygen compounds containing diethylzinc and pyrocatechol or saligenin moieties“. Journal of Organometallic Chemistry 384, Nr. 1-2 (Februar 1990): 13–17. http://dx.doi.org/10.1016/0022-328x(90)87048-i.
Der volle Inhalt der QuelleKakimoto, Takeshi, Takahiro Shiotsuki und Morifusa Eto. „Reaction of Saligenin Cyclic Phosphorus Esters with Some Amino Acids and Purine and Pyrimidine Bases“. Journal of the Faculty of Agriculture, Kyushu University 37, Nr. 3/4 (März 1993): 371–77. http://dx.doi.org/10.5109/24030.
Der volle Inhalt der QuelleMentzschel, Anke, Gabi Schmuck, Wolfgang Dekant und Dietrich Henschler. „Genotoxicity of neurotoxic triaryl phosphates: Identification of DNA adducts of the ultimate metabolites, saligenin phosphates“. Chemical Research in Toxicology 6, Nr. 3 (Mai 1993): 294–301. http://dx.doi.org/10.1021/tx00033a007.
Der volle Inhalt der QuelleProcopiou, Panayiotis A., Victoria J. Barrett, Nicola J. Bevan, Peter R. Butchers, Richard Conroy, Amanda Emmons, Alison J. Ford et al. „The discovery of long-acting saligenin β2 adrenergic receptor agonists incorporating hydantoin or uracil rings“. Bioorganic & Medicinal Chemistry 19, Nr. 14 (Juli 2011): 4192–201. http://dx.doi.org/10.1016/j.bmc.2011.05.064.
Der volle Inhalt der QuelleBursian, S. J., E. J. Lehning, L. Correll und M. Ehrich. „Effect of β‐naphthoflavone ono‐tolyl saligenin phosphate‐induced delayed neuropathy in two lines of chickens“. Journal of Toxicology and Environmental Health 28, Nr. 4 (Dezember 1989): 461–71. http://dx.doi.org/10.1080/15287398909531364.
Der volle Inhalt der QuelleShiotsuki, Takahiro, Akihiro Koiso und Morifusa Eto. „Inhibition of glutathione transferase by S-benzyl glutathione analogous to the conjugate of saligenin cyclic phosphate“. Pesticide Biochemistry and Physiology 37, Nr. 2 (Juni 1990): 121–29. http://dx.doi.org/10.1016/0048-3575(90)90117-k.
Der volle Inhalt der QuelleRishina, Laura A., Svetlana S. Lalayan, Svetlana C. Gagieva, Vladislav A. Tuskaev, Evgeniya O. Perepelitsyna und Yury V. Kissin. „Polymers of propylene and higher 1-alkenes produced with post-metallocene complexes containing a saligenin-type ligand“. Polymer 54, Nr. 24 (November 2013): 6526–35. http://dx.doi.org/10.1016/j.polymer.2013.09.052.
Der volle Inhalt der QuelleFelemban, Shatha G., A. Christopher Garner, Fathi A. Smida, David J. Boocock, Alan J. Hargreaves und John M. Dickenson. „Phenyl Saligenin Phosphate Induced Caspase-3 and c-Jun N-Terminal Kinase Activation in Cardiomyocyte-Like Cells“. Chemical Research in Toxicology 28, Nr. 11 (23.10.2015): 2179–91. http://dx.doi.org/10.1021/acs.chemrestox.5b00338.
Der volle Inhalt der QuellePruett, Stephen B., und Janice E. Chambers. „Effects of paraoxon, p-nitrophenol, phenyl saligenin cyclic phosphate, and phenol on the rat interleukin 2 system“. Toxicology Letters 40, Nr. 1 (Januar 1988): 11–20. http://dx.doi.org/10.1016/0378-4274(88)90178-6.
Der volle Inhalt der QuelleEhrich, Marion, Linda Shell, Michael Rozum und B. S. Jortner. „Short-term Clinical and Neuropathologic Effects of Cholinesterase Inhibitors in Rats“. Journal of the American College of Toxicology 12, Nr. 1 (Januar 1993): 55–68. http://dx.doi.org/10.3109/10915819309140622.
Der volle Inhalt der QuelleDucho, Christian, Jan Balzarini, Lieve Naesens, Erik De Clercq und Chris Meier. „Aryl-Substituted and Benzo-Annulated CycloSal-Derivatives of 2′,3′-Dideoxy-2′,3′-Didehydrothymidine Monophosphate — Correlation of Structure, Hydrolysis Properties and Anti-HIV Activity“. Antiviral Chemistry and Chemotherapy 13, Nr. 2 (April 2002): 129–41. http://dx.doi.org/10.1177/095632020201300206.
Der volle Inhalt der QuelleMassicotte, Christiane, David S. Barber, Bernard S. Jortner und Marion Ehrich. „Nerve Conduction and ATP Concentrations in Sciatic-Tibial and Medial Plantar Nerves of Hens Given Phenyl Saligenin Phosphate“. NeuroToxicology 22, Nr. 1 (Februar 2001): 91–98. http://dx.doi.org/10.1016/s0161-813x(00)00004-8.
Der volle Inhalt der QuelleKumar, Sumit, Santosh K. Singh, Camilla Calabrese, Assimo Maris, Sonia Melandri und Aloke Das. „Structure of saligenin: microwave, UV and IR spectroscopy studies in a supersonic jet combined with quantum chemistry calculations“. Physical Chemistry Chemical Physics 16, Nr. 32 (10.07.2014): 17163. http://dx.doi.org/10.1039/c4cp01693a.
Der volle Inhalt der QuelleRishina, Laura, Svetlana Lalayan, Svetlana Gagieva, Vladislav Тuskaev, Alexander Shchegolikhin, Dimitri Shashkin und Yury Kissin. „Titanium Complex Containing a Saligenin Ligand - New Universal Post-Metallocene Polymerization Catalyst: Copolymerization of Ethylene with Higher α-Olefins“. Journal of Research Updates in Polymer Science 3, Nr. 4 (05.01.2015): 216–26. http://dx.doi.org/10.6000/1929-5995.2014.03.04.3.
Der volle Inhalt der QuelleMcCain, W. C., J. Wilcke, J. C. Lee und M. Ehrich. „Effect of cyclic phenyl saligenin phosphate and paraoxon treatment on vascular response to adrenergic and cholinergic agents in hens“. Journal of Toxicology and Environmental Health 44, Nr. 2 (Februar 1995): 167–87. http://dx.doi.org/10.1080/15287399509531953.
Der volle Inhalt der QuelleHarp, Paul, Duke Tanaka und Carey N. Pope. „Potentiation of Organophosphorus-Induced Delayed Neurotoxicity Following Phenyl Saligenin Phosphate Exposures in 2-, 5-, and 8-Week-Old Chickens“. Toxicological Sciences 37, Nr. 1 (1997): 64–70. http://dx.doi.org/10.1093/toxsci/37.1.64.
Der volle Inhalt der QuelleHarris, W., D. Muñoz, P. L. R. Bonner und A. J. Hargreaves. „Effects of phenyl saligenin phosphate on cell viability and transglutaminase activity in N2a neuroblastoma and HepG2 hepatoma cell lines“. Toxicology in Vitro 23, Nr. 8 (Dezember 2009): 1559–63. http://dx.doi.org/10.1016/j.tiv.2009.08.029.
Der volle Inhalt der QuelleLiyasova, Mariya S., Lawrence M. Schopfer und Oksana Lockridge. „Cresyl Saligenin Phosphate, an Organophosphorus Toxicant, Makes Covalent Adducts with Histidine, Lysine, and Tyrosine Residues of Human Serum Albumin“. Chemical Research in Toxicology 25, Nr. 8 (26.07.2012): 1752–61. http://dx.doi.org/10.1021/tx300215g.
Der volle Inhalt der QuelleHarp, P. „Potentiation of Organophosphorus-Induced Delayed Neurotoxicity Following Phenyl Saligenin Phosphate Exposures in 2-, 5-, and 8-Week-Old Chickens“. Fundamental and Applied Toxicology 37, Nr. 1 (Mai 1997): 64–70. http://dx.doi.org/10.1006/faat.1997.2301.
Der volle Inhalt der QuelleMccain, W. C., J. C. Lee, J. R. Wilcke und M. Ehrich. „The Effect of Phenyl Saligenin Cyclic Phosphate Induced Delayed Neuropathy on Selected Hemodynamic and Hematologic Parameters in the Hen“. Pesticide Biochemistry and Physiology 45, Nr. 3 (März 1993): 220–27. http://dx.doi.org/10.1006/pest.1993.1024.
Der volle Inhalt der QuelleHausherr, Vanessa, Nicole Schöbel, Julia Liebing und Christoph van Thriel. „Assessment of neurotoxic effects of tri-cresyl phosphates (TCPs) and cresyl saligenin phosphate (CBDP) using a combination of in vitro techniques“. NeuroToxicology 59 (März 2017): 210–21. http://dx.doi.org/10.1016/j.neuro.2016.06.005.
Der volle Inhalt der QuelleLiyasova, Mariya S., Lawrence M. Schopfer und Oksana Lockridge. „Cresyl saligenin phosphate makes multiple adducts on free histidine, but does not form an adduct on histidine 438 of human butyrylcholinesterase“. Chemico-Biological Interactions 203, Nr. 1 (März 2013): 103–7. http://dx.doi.org/10.1016/j.cbi.2012.07.006.
Der volle Inhalt der QuelleFox, Jonathan H., Bernard S. Jortner, David Barber und Marion F. Ehrich. „Altered expression of transcripts for ?-tubulin and an unidentified gene in the spinal cord of phenyl saligenin phosphate treated hens (Gallus gallus)“. Journal of Biochemical and Molecular Toxicology 17, Nr. 5 (2003): 263–71. http://dx.doi.org/10.1002/jbt.10088.
Der volle Inhalt der QuelleMasson, Patrick, Sofya Lushchekina, Lawrence M. Schopfer und Oksana Lockridge. „Effects of viscosity and osmotic stress on the reaction of human butyrylcholinesterase with cresyl saligenin phosphate, a toxicant related to aerotoxic syndrome: kinetic and molecular dynamics studies“. Biochemical Journal 454, Nr. 3 (29.08.2013): 387–99. http://dx.doi.org/10.1042/bj20130389.
Der volle Inhalt der QuelleAlmami, Ibtesam S., Maha A. Aldubayan, Shatha G. Felemban, Najiah Alyamani, Richard Howden, Alexander J. Robinson, Tom D. Z. Pearson et al. „Neurite outgrowth inhibitory levels of organophosphates induce tissue transglutaminase activity in differentiating N2a cells: evidence for covalent adduct formation“. Archives of Toxicology 94, Nr. 11 (04.08.2020): 3861–75. http://dx.doi.org/10.1007/s00204-020-02852-w.
Der volle Inhalt der QuelleCarlson, Kent, und Marion Ehrich. „Organophosphorus Compound–Induced Delayed Neurotoxicity in White Leghorn Hens Assessed by Fluoro-Jade“. International Journal of Toxicology 23, Nr. 4 (Juli 2004): 259–66. http://dx.doi.org/10.1080/10915810490504968.
Der volle Inhalt der QuelleFelemban, Shatha G., Falguni S. Vyas, Lyndsey Durose, Alan J. Hargreaves und John M. Dickenson. „Phenyl Saligenin Phosphate Disrupts Cell Morphology and the Actin Cytoskeleton in Differentiating H9c2 Cardiomyoblasts and Human-Induced Pluripotent Stem-Cell-Derived Cardiomyocyte Progenitor Cells“. Chemical Research in Toxicology 33, Nr. 9 (06.08.2020): 2310–23. http://dx.doi.org/10.1021/acs.chemrestox.0c00100.
Der volle Inhalt der QuelleMcCain, Wilfred C., Diane M. Flaherty, Linda Correll, Bernard Jortner und Marion Ehrich. „CATECHOLAMINE CONCENTRATIONS AND CONTRACTILE RESPONSES OF ISOLATED VESSELS FROM HENS TREATED WITH CYCLIC PHENYL SALIGENIN PHOSPHATE OR PARAOXON IN THE PRESENCE OR ABSENCE OF VERAPAMIL“. Journal of Toxicology and Environmental Health 48, Nr. 4 (Juli 1996): 397–411. http://dx.doi.org/10.1080/009841096161276.
Der volle Inhalt der QuelleKart, Asim, und Ali Bilgili. „Effects of organophosphate phenyl saligenin phosphate and polyether carboxylic ionophore lasalocid on motor nerve conduction velocity, neuropathy target esterase enzyme activity, and clinical ataxia in chickens“. Toxicology Mechanisms and Methods 19, Nr. 5 (Juni 2009): 351–55. http://dx.doi.org/10.1080/15376510903030403.
Der volle Inhalt der QuelleCarletti, Eugénie, Lawrence M. Schopfer, Jacques-Philippe Colletier, Marie-Thérèse Froment, Florian Nachon, Martin Weik, Oksana Lockridge und Patrick Masson. „Reaction of Cresyl Saligenin Phosphate, the Organophosphorus Agent Implicated in Aerotoxic Syndrome, with Human Cholinesterases: Mechanistic Studies Employing Kinetics, Mass Spectrometry, and X-ray Structure Analysis“. Chemical Research in Toxicology 24, Nr. 6 (20.06.2011): 797–808. http://dx.doi.org/10.1021/tx100447k.
Der volle Inhalt der QuelleDuysen, Ellen G., John R. Cashman, Lawrence M. Schopfer, Florian Nachon, Patrick Masson und Oksana Lockridge. „Differential sensitivity of plasma carboxylesterase-null mice to parathion, chlorpyrifos and chlorpyrifos oxon, but not to diazinon, dichlorvos, diisopropylfluorophosphate, cresyl saligenin phosphate, cyclosarin thiocholine, tabun thiocholine, and carbofuran“. Chemico-Biological Interactions 195, Nr. 3 (Februar 2012): 189–98. http://dx.doi.org/10.1016/j.cbi.2011.12.006.
Der volle Inhalt der Quelle